ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CRSP CRISPR Therapeutics AG

55.26
1.45 (2.69%)
May 02 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
CRISPR Therapeutics AG CRSP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.45 2.69% 55.26 18:59:31
Open Price Low Price High Price Close Price Previous Close
54.48 54.00 55.34 55.07 53.81
more quote information »

Recent News

Date Time Source Heading
4/22/202415:30GLOBECRISPR Therapeutics to Present Oral Presentation at the..
4/03/202407:00GLOBECRISPR Therapeutics to Present at the Annual Needham Virtual..
4/01/202407:00GLOBECRISPR Therapeutics to Present at the American Society of..
3/13/202407:30GLOBECRISPR Therapeutics Proposes New Appointment to the Board of..
2/21/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202406:50EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/21/202406:45EDGAR2Form 8-K - Current report
2/21/202406:30GLOBECRISPR Therapeutics Provides Business Update and Reports..
2/16/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202415:30EDGAR2Form 144 - Report of proposed sale of securities
2/15/202407:30GLOBECRISPR Therapeutics to Present at the Citi 2024 Virtual..
2/13/202407:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/13/202407:30GLOBECRISPR Therapeutics Announces $280 Million Registered Direct..
2/13/202405:30EDGAR2Form 8-K - Current report
2/13/202401:30GLOBEEuropean Commission Approves First CRISPR/Cas9 Gene-Edited..
1/31/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202415:08EDGAR2Form 144 - Report of proposed sale of securities
1/29/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/18/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202416:00EDGAR2Form 144 - Report of proposed sale of securities
1/16/202415:11EDGAR2Form 8-K - Current report
1/16/202415:01GLOBECRISPR Therapeutics Announces U.S. Food and Drug..
1/10/202410:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/08/202406:00GLOBECRISPR Therapeutics Highlights Strategic Priorities and 2024..
1/03/202407:30GLOBECRISPR Therapeutics to Present at the 42nd Annual J.P...
12/19/202315:23EDGAR2Form 8-K - Current report
12/15/202307:58EDGAR2Form 8-K - Current report
12/13/202308:22EDGAR2Form 8-K - Current report
12/08/202315:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
12/08/202312:16EDGAR2Form 8-K - Current report
12/08/202311:52BWVertex and CRISPR Therapeutics Announce US FDA Approval of..
12/08/202310:46DJNCRISPR, Vertex Get FDA OK of Casgevy Gene Therapy in..
12/04/202315:26EDGAR2Form 8-K - Current report
12/04/202315:15GLOBECRISPR Therapeutics Announces Updates to Immuno-Oncology..
11/16/202306:21EDGAR2Form 8-K - Current report
11/16/202300:45BW Vertex and CRISPR Therapeutics Announce Authorization of..
11/06/202315:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202315:33EDGAR2Form 8-K - Current report
11/06/202315:15GLOBECRISPR Therapeutics Provides Business Update and Reports..
11/06/202304:01GLOBECRISPR Therapeutics Announces Preclinical Data at the..
11/01/202305:29DJNCrispr Therapeutics Shares Rally Premarket After Favorable..
10/31/202316:53GLOBECRISPR Therapeutics Announces Completion of FDA Advisory..
10/31/202306:05GLOBECRISPR Therapeutics Trading Halted Today; FDA Advisory..
10/17/202316:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/17/202316:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/17/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/17/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/16/202307:00GLOBECRISPR Therapeutics Proposes New Appointment to the Board of..
9/27/202308:01GLOBECRISPR Therapeutics to Present at the Society for..

Your Recent History

Delayed Upgrade Clock